US Patent Issued to Wisconsin Alumni Research Foundation on March 3 for "Long-lived gadolinium based tumor targeted imaging and therapy agents" (Wisconsin, New York Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,635, issued on March 3, was assigned to Wisconsin Alumni Research Foundation (Madison, Wis.).

"Long-lived gadolinium based tumor targeted imaging and therapy agents" was invented by Jamey Weichert (Sun Prairie, Wis.), Anatoly Pinchuk (Fitchburg, Wis.) and Wolfgang Axel Tome (Ardsley, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Alkylphosphocholine analogs incorporating a chelating moiety that is chelated to gadolinium are disclosed herein. The alkylphophocholine analogs are compounds having the formula:or a salt thereof. R1 includes a chelating agent that is chelated to a gadolinium atom; a is 0 or 1; n is an integer from 12 to 30; m is 0 or ...